The decision is remarkable in that the HIV integrase inhibitor is one of ViiV’s most up-to-date products, only getting FDA approval under the Apretude brand ... GSK also said the new agreements ...

LONDON, Feb 27 (Reuters) - British drugmaker GSK (GSK.L), opens new tab will no longer set diversity targets, it said on Thursday, as it became the latest company to scale back or abandon such ...

In January, price increases contributed over 5% to growth, new product introductions added 2.6%, while volume growth was 0.9%. Augmentin maintained its position as the top-selling brand with Rs 75 ...

GSK Plc is a long-term underperformer among Europe’s Big Pharma stocks. And with key drug patents set to expire and vaccine sales falling, some market participants say it may draw in activist ...

NEW YORK, NY / ACCESS Newswire / March 10, 2025 / If you suffered a loss on your GSK plc (NYSE:GSK) investment and want to learn about a ...

During Walmsley’s near eight-year tenure, GSK shares have delivered a total annualized return of about 3%, compared with more than 7% for peers, according to data compiled by Bloomberg.